FRG Family Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $570K | Sell |
20,298
-5,437
| -21% | -$145K | 0.09% | 109 |
|
|
2025
Q4 | $641K | Sell |
25,735
-114
| -0.4% | -$2.88K | 0.1% | 105 |
|
|
2025
Q3 | $659K | Sell |
25,849
-1,100
| -4% | -$27.1K | 0.11% | 102 |
|
|
2025
Q2 | $653K | Sell |
26,949
-2,560
| -9% | -$59.7K | 0.11% | 95 |
|
|
2025
Q1 | $748K | Sell |
29,509
-15,006
| -34% | -$393K | 0.14% | 92 |
|
|
2024
Q4 | $1.18M | Hold |
44,515
| – | – | 0.21% | 70 |
|
|
2024
Q3 | $1.29M | Buy |
44,515
+165
| +0.4% | +$4.81K | 0.23% | 67 |
|
|
2024
Q2 | $1.3M | Sell |
44,350
-6,360
| -13% | -$175K | 0.25% | 63 |
|
|
2024
Q1 | $1.3M | Sell |
50,710
-7,570
| -13% | -$210K | 0.25% | 61 |
|
|
2023
Q4 | $1.68M | Sell |
58,280
-10,822
| -16% | -$327K | 0.34% | 50 |
|
|
2023
Q3 | $2.29M | Sell |
69,102
-685
| -1% | -$24.2K | 0.52% | 41 |
|
|
2023
Q2 | $2.56M | Sell |
69,787
-4,921
| -7% | -$192K | 0.56% | 37 |
|
|
2023
Q1 | $3.05M | Sell |
74,708
-2,305
| -3% | -$99.6K | 0.7% | 37 |
|
|
2022
Q4 | $3.95M | Sell |
77,013
-3,170
| -4% | -$152K | 0.94% | 32 |
|
|
2022
Q3 | $3.51M | Buy |
80,183
+925
| +1% | +$44.9K | 0.87% | 31 |
|
|
2022
Q2 | $4.16M | Hold |
79,258
| – | – | 0.96% | 30 |
|
|
2022
Q1 | $4.1M | Buy |
79,258
+100
| +0.1% | +$5.19K | 0.8% | 33 |
|
|
2021
Q4 | $4.67M | Sell |
79,158
-200
| -0.3% | -$9.91K | 0.87% | 30 |
|
|
2021
Q3 | $3.41M | Sell |
79,358
-2,402
| -3% | -$106K | 0.67% | 34 |
|
|
2021
Q2 | $3.2M | Sell |
81,760
-1,135
| -1% | -$44.1K | 0.61% | 37 |
|
|
2021
Q1 | $3M | Sell |
82,895
-1,033
| -1% | -$36.7K | 0.61% | 39 |
|
|
2020
Q4 | $3.09M | Sell |
83,928
-5,038
| -6% | -$185K | 0.67% | 38 |
|
|
2020
Q3 | $3.1M | Sell |
88,966
-2,076
| -2% | -$72.8K | 0.75% | 37 |
|
|
2020
Q2 | $2.83M | Sell |
91,042
-512
| -0.6% | -$17.4K | 0.75% | 39 |
|
|
2020
Q1 | $2.83M | Sell |
91,554
-5,371
| -6% | -$183K | 0.86% | 34 |
|
|
2019
Q4 | $3.6M | Sell |
96,925
-13,059
| -12% | -$465K | 0.87% | 33 |
|
|
2019
Q3 | $3.75M | Buy |
109,984
+6,229
| +6% | +$227K | 0.97% | 33 |
|
|
2019
Q2 | $4.26M | Buy |
103,755
+1,239
| +1% | +$49.2K | 1.12% | 28 |
|
|
2019
Q1 | $4.13M | Buy |
102,516
+1,412
| +1% | +$56.5K | 1.17% | 26 |
|
|
2018
Q4 | $4.19M | Buy |
101,104
+4,074
| +4% | +$169K | 1.37% | 18 |
|
|
2018
Q3 | $4.06M | Buy |
97,030
+8,843
| +10% | +$340K | 1.11% | 23 |
|
|
2018
Q2 | $3.04M | Buy |
88,187
+6,935
| +9% | +$237K | 0.91% | 31 |
|
|
2018
Q1 | $2.74M | Buy |
81,252
+2,870
| +4% | +$98.7K | 0.91% | 39 |
|
|
2017
Q4 | $2.69M | Buy |
78,382
+711
| +0.9% | +$24.2K | 0.87% | 43 |
|
|
2017
Q3 | $2.63M | Buy |
77,671
+126
| +0.2% | +$4.05K | 0.91% | 39 |
|
|
2017
Q2 | $2.47M | Buy |
77,545
+1,192
| +2% | +$37.6K | 0.91% | 39 |
|
|
2017
Q1 | $2.49M | Buy |
76,353
+2,951
| +4% | +$93K | 0.97% | 36 |
|
|
2016
Q4 | $2.26M | Buy |
73,402
+1,989
| +3% | +$60.7K | 0.95% | 36 |
|
|
2016
Q3 | $2.29M | Buy |
71,413
+1,033
| +1% | +$34.5K | 1.03% | 32 |
|
|
2016
Q2 | $2.35M | Buy |
70,380
+2,929
| +4% | +$93.5K | 1.06% | 30 |
|
|
2016
Q1 | $1.92M | Buy |
67,451
+606
| +0.9% | +$17.3K | 0.93% | 37 |
|
|
2015
Q4 | $2.05M | Buy |
+66,845
| New | +$2.1M | 1% | 34 |
|
Other funds holding PFE
FRG Family Wealth Advisors's PFE Position: Q1 2026 in Review
FRG Family Wealth Advisors reduced its Pfizer (PFE) stake by 21% in Q1 2026, selling an estimated $145K and leaving 20,298 shares worth $570K. The position accounts for 0.09% of the portfolio, ranked #109.
FRG Family Wealth Advisors first reported a position in PFE in Q4 2015 and has held it in 42 quarters since. The position peaked at $4.67M in Q4 2021. 2,955 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- FRG Family Wealth Advisors held 20,298 shares of Pfizer worth $570K as of Q1 2026.
- FRG Family Wealth Advisors sold 5,437 Pfizer shares in Q1 2026, an estimated $145K.
- Pfizer made up 0.09% of FRG Family Wealth Advisors's portfolio in Q1 2026, its #109 holding.
- FRG Family Wealth Advisors first reported a position in Pfizer in Q4 2015 and has held it in 42 quarters since.
- FRG Family Wealth Advisors's Pfizer position peaked at $4.67M in Q4 2021.
- 2,955 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on FRG Family Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.